JRS Pharma to offer povidone products

Published: 22-Jul-2016 Featured companies: JRS Pharma
Ingredients Finance

Strategic alliance expands company's product portfolio


JRS Pharma has entered into a joint venture agreement with SSP to commercialise povidone products. The new joint venture company is Star-Tech & JRS Specialty Products.

Equipped with innovative technology and a state-of-the-art GMP-compliant production facility, Star-Tech & JRS Specialty Products specialises in the manufacture of high quality povidones with CEP certification for life sciences applications.

JRS Pharma, an innovative leader in the development, manufacture and distribution of high quality pharmaceutical and nutraceutical excipients, will assume the overall quality responsibility for all Vivapharm povidone products through final quality checks in the newly established Analytic Competence Center in Germany.

JRS Pharma will also manage all R&D, marketing and sales of povidone products for the health science industry.

This strategic alliance expands the JRS Pharma product portfolio, resulting in an even more comprehensive solution to its customers’ needs. The joint venture capitalises on JRS Pharma’s strong global presence, along with the technical support offered by four Technical Competence Centers worldwide.

Featured companies

JRS Pharma is a first class manufacturer of excipients, offering a complete portfolio of solutions for the nutraceutical and pharmaceutical industries.
See more

You may also like

Ingredients

Introducing the next generation of high functionality excipients

Read more
PROSOLV 730 - Directly compressible carrier for lipophilic ingredients

Trending Articles

  1. Solabia Nutrition's Brainberry incorporated into Flow's cognition-supporting functional chocolate Looking past the headlines, NBR find out more about the nootropic, L-theanine and caffeine-boosted functional food and how enhanced sweet treats are impacting the industry
  2. Mythbusting study highlights the heart health benefits of omega-6 fatty acids A new report has highlighted the benefits of omega-6 intake — specifically linoleic acid — in reducing the risk of cardiovascular disease, type II diabetes and elevated cholesterol levels
  3. Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
  4. Beneo supports the plant-based functional food market at Fi Europe 2024 The company will display its range of plant-based meat, cheese and chocolate alternatives which are high in nutritional ingredients such as fibre and protein
  5. Kimchi supplement could combat obesity by reducing body fat, study finds Overweight adults given kimchi exhibited a 7.3% decrease in body fat compared with the placebo group, while also experiencing positive changes to their gut microbiome composition

Relevant companies

See more

Upcoming event

Vitafoods India

5–7 February 2025 | Exhibition | Mumbai See all

You may also like

Ingredients

Introducing the next generation of high functionality excipients

PROSOLV 730 - Directly compressible carrier for lipophilic ingredients
Manufacturing

JRS Pharma introduces titanium dioxide-free coating

Ti02 will be banned as a food additive in the EU in 2022, with regulations expected to follow in other regions
Ingredients

JRS PHARMA announces the worldwide availability of VIVAPHARM Pectins

VIVAPHARM Pectins are made from locally sourced fresh citrus peels, with additional dried peels imported to ensure supply security
Ingredients

PROSOLV EASYtab Nutra: The all-in-one excipient composite

Formulators can simplify the production of nutritional tablets while still producing robust formulations
Ingredients

JRS Pharma taps into Chinese market with cDMF filings for excipients portfolio

Ingredients by the German excipient maker have been included in the Chinese Drug Master File with the National Medical Products Administration
Ingredients

JRS Pharma introduces new excipient for nutritional products

PROSOLV EASYtab NUTRA (all-in-one, ready-to-use excipient composite)
Ingredients

Vitamin B3 diminishes lung inflammation in COPD patients, study reveals

Supplementation with vitamin B3 was found to reduce lung inflammatory biomarkers by up to 63%, while also increasing blood NAD levels in those with COPD
Subscribe now